A Study of a Sleep Health ‘App’ to Help First-Time Users of Positive Airway Pressure Therapy for Sleep Apnea

Overview

About this study

The purpose of this study is to test the usefullness and initial effectiveness of an mHealth smartphone app to increase use of positive airway pressure (PAP) therapy in obstructive sleep apnea (OSA) patients treated at the Mayo Clinic Arizona Center for Sleep Medicine.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

CLOSED FOR ENROLLMENT

Inclusion Criteria

  • Age 21+ years
  • Positive screen for moderate to severe obstructive sleep apnea using the Sleep Apnea Clinical Score screener
  • Clinical diagnostic testing via laboratory or home-based sleep study indicates diagnosis of obstructive sleep apnea
  • Currently uses an appropriate Apple (iOS7 or higher) or Android (2.3 or higher) smartphone device
  • Is able to read and understand English
  • Has been prescribed PAP treatment for obstructive sleep apnea

Exclusion Criteria 

  • Does not agree to be randomized
  • Is currently participating in other lifestyle programs (e.g., active, formal weight loss program or research study; smoking cessation program, etc.)
  • Has lost 10lb or 4.5kg over the past 4 weeks
  • Has personal, health (e.g., stroke), cognitive (e.g., dementia) or psychological conditions that prevent participation
  • Is pregnant, lactating, or trying to become pregnant
  • Decide to use different device than ResMED Airsense 10
  • Prescribed high-dose benzodiazepines (equivalent to >1 mg lorazapam/night)
  • Daily opioid medication use at night
  • Unwilling to discontinue use of any current wearable sensor for the duration of the trial
  • Unwilling to consent for out-of-pocket costs
  • Previous documented history of treatment/referral for claustrophobia
  • Previous PAP use
  • Other conditions determined by a sleep medicine team member that may interfere with full participation in the trial
  • Planning to travel for more than seven consecutive nights during the trial
  • Currently engaging in shiftwork defined as night shift or rotating day and night shifts
  • Unwilling to have an in-person follow-up appointment at the Center for Sleep Medicine, Arizona

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Park, M.D.

Closed for enrollment

Contact information:

Luke Teigen B.S.

(507)266-6627

Teigen.Luke@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Lois Krahn, M.D.

Closed for enrollment

Contact information:

Megan Kelly M.H.A.

(480)342-1248

Kelly.Megan1@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20258281

Mayo Clinic Footer